“AI won’t replace drug scientists— it supercharges them: faster discovery + cheaper testing.”

“The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.”

“Innovation drug dreams are traded for 'life-sustaining funds'.”

“The challenge is no longer whether AI can help, but how tightly it needs to be built into research and clinical work to improve decisions around trials and treatment.”

“NVIDIA founder and CEO Jensen Huang told attendees… ‘a blueprint for what is possible in the future of drug discovery’”

“OpenAI and Anthropic have each launched healthcare-focused products over the last week.”

“Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.”

“Lots of companies have also deprecated their internally built solution to switch over, dealing with GPU infra and onboarding docker containers not being a very exciting problem when the company you work for is trying to cure cancer.”

“…the first drug generated entirely by generative artificial intelligence to reach mid-stage human clinical trials, and the first to target a novel AI-discovered biological pathway”

“The article itself is very short and doesn't contain any direct quotes. The information is presented as a summary of a discovery.”

“DTI-GP outperforms state-of-the-art solutions, and it allows (1) the construction of a Bayesian accuracy-confidence enrichment score, (2) rejection schemes for improved enrichment, and (3) estimation and search for top-$K$ selections and ranking with high expected utility.”

“SeedProteo achieves state-of-the-art performance among open-source methods, attaining the highest in-silico design success rates, structural diversity and novelty.”

“The model generates syntactically valid structures (100% validity achieved via rejection sampling) and 94.8% unique structures.”

“BioSelectTune achieves state-of-the-art (SOTA) performance across multiple BioNER benchmarks. Notably, our model, trained on only 50% of the curated positive data, not only surpasses the fully-trained baseline but also outperforms powerful domain-specialized models like BioMedBERT.”

“The study's results show that these models can generate valid, diverse, and biologically relevant compounds across multiple targets, with a few selected GSK-3β hits synthesized and confirmed active in vitro.”

“DuaDeep-SeqAffinity significantly outperforms individual architectural components and existing state-of-the-art (SOTA) methods.”

“The lead compound M2 not only exhibits potent antibacterial activity, with a minimum inhibitory concentration (MIC) of 25.6 ug/mL, but also achieves binding stability superior to cefuroxime...”

“The article proposes the use of an orchestrated, knowledge-driven multi-agent team for user-guided therapeutic design.”

“AVP-Fusion utilizes adaptive multi-modal fusion and contrastive learning.”

“”

“”

“The study investigates how stylistic features influence predictions on public benchmarks.”

“Network-based prediction of drug combinations with quantum annealing”

“The paper focuses on out-of-distribution detection in molecular complexes.”

“”

“The article discusses the 'dual-LAO' method.”

“The paper focuses on scalable agentic reasoning for designing biologics.”

“The research focuses on multi-modal generative molecular elucidation from IR and NMR spectra.”

“”

“Accelerating MHC-II Epitope Discovery via Multi-Scale Prediction in Antigen Presentation”

“The article's context indicates the research is published on ArXiv.”

“The paper focuses on advanced guidance strategies for conditional molecular generation with flow matching.”

“The research focuses on molecular toxicity prediction using chemical language models.”

“The research focuses on benchmarking microscopic spatial intelligence on molecules via vision-language models.”

“”

“"AlphaFold represents a paradigm shift in structural biology."”

“DynaMate is an autonomous agent for protein-ligand molecular dynamics simulations.”

“The paper focuses on closed-loop molecular discovery.”

“”

“The author's profile includes their name, location, educational background, and areas of expertise, such as AI, machine learning, and computational drug discovery.”

“”

“OMTRA is a multi-task generative model for structure-based drug design.”

“”

“"AlphaFold represents a paradigm shift in structural biology."”

“The research focuses on using in-context learning and test-time training.”

“A Complete and Modification-Aware DAVIS Dataset”

“The paper focuses on drug-gene-ADR prediction.”

“AtomDisc is an atom-level tokenizer.”

“The article is sourced from ArXiv.”

“The article is likely a research paper, focusing on a specific AI-driven methodology for a biomedical application.”